British Journal of Dermatology

Research Snippets
pp. iv-iv(1)

Toxic epidermal necrolysis: current evidence, practical management and future directions
pp. 241-253(13)
Authors: Chave, T.A.; Mortimer, N.J.; Sladden, M.J.; Hall, A.P.; Hutchinson, P.E.

Thalidomide: dermatological indications, mechanisms of action and side-effects
pp. 254-273(20)
Authors: Wu, J.J.; Huang, D.B.; Pang, K.R.; Hsu, S.; Tyring, S.K.

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases
pp. 274-281(8)
Authors: Komatsu, N.; Saijoh, K.; Toyama, T.; Ohka, R.; Otsuki, N.; Hussack, G.; Takehara, K.; Diamandis, E.P.

Role of breast tumour kinase in the in vitro differentiation of HaCaT cells
pp. 282-289(8)
Authors: Wang, T.C.; Jee, S.H.; Tsai, T.F.; Huang, Y.L.; Tsai, W.L.; Chen, R.H.

Comparative genomic hybridization in extramammary Paget's disease
pp. 290-294(5)
Authors: Lee, M-W.; Jee, K-J.; Gong, G-Y.; Choi, J-H.; Moon, K-C.; Koh, J-K.

Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration
pp. 295-300(6)
Authors: Fujiwara, M.; Muragaki, Y.; Ooshima, A.

Differential expression of nitric oxide synthases in human scalp epidermal and hair follicle pigmentary units: implications for regulation of melanogenesis
pp. 301-309(9)
Authors: Sowden, H.M.; Naseem, K.M.; Tobin, D.J.

Hereditary mucoepithelial dysplasia: clinical, ultrastructural and genetic study of eight patients and literature review
pp. 310-318(9)
Authors: Boralevi, F.; Haftek, M.; Vabres, P.; Lepreux, S.; Goizet, C.; Leaute-Labreze, C.; Taieb, A.

Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis
pp. 319-323(5)
Authors: Sakai, S.; Kikuchi, K.; Satoh, J.; Tagami, H.; Inoue, S.

Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides
pp. 324-330(7)
Authors: Abeni, D.; Frontani, M.; Sampogna, F.; Sera, F.; Bolli, S.; Corona, R.; Baliva, G.; Russo, G.

Thyroid autoimmunity in chronic urticaria
pp. 331-335(5)
Authors: O'Donnell, B.F.; Francis, D.M.; Swana, G.T.; Seed, P.T.; Kobza Black, A.; Greaves, M.W.

A systematic review of placebo-controlled randomized clinical trials of treatments used in oral lichen planus
pp. 336-341(6)
Authors: Zakrzewska, J.M.; Chan, E.S-Y.; Thornhill, M.H.

The double-RNA-specific adenosine deaminase (DSRAD) gene in dyschromatosis symmetrica hereditaria patients: two novel mutations and one previously described
pp. 342-345(4)
Authors: Sun, X-K.; Xu, A-E.; Chen, J-F.; Tang, X.

Psoriasis in Norway as observed in a population-based Norwegian twin panel
pp. 346-351(6)
Authors: Olsen, A.O.; Grjibovski, A.; Magnus, P.; Tambs, K.; Harris, J.R.

A comparison between criteria for diagnosing atopic eczema in infants
pp. 352-358(7)
Authors: Jøhnke, H.; Vach, W.; Norberg, L.A.; Bindslev-Jensen, C.; Høst, A.; Andersen, K.E.

Serum antidiuretic hormone is elevated in relation to the increase in average total body transepidermal water loss in severe atopic dermatitis
pp. 359-363(5)
Author: Aoki, T.

Analysis of para-phenylenediamine allergic patients in relation to strength of patch test reaction
pp. 364-367(4)
Authors: Ho, S.G.Y.; Basketter, D.A.; Jefferies, D.; Rycroft, R.J.G.; White, I.R.; Mcfadden, J.P.

The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma
pp. 368-371(4)
Authors: Alessi, E.; Coggi, A.; Venegoni, L.; Merlo, V.; Gianotti, R.

The development of a preference-based measure of health in children with atopic dermatitis
pp. 372-377(6)
Authors: Stevens, K.J.; Brazier, J.E.; McKenna, S.P.; Doward, L.C.; Cork, M.J.

Sunscreens and melanoma: the future looks bright
pp. 378-381(4)
Author: Diffey, B.L.

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades
pp. 382-389(8)
Authors: Seoane Reula, E.; Bellon, J.M.; Gurbindo, D.; Muñoz-Fernandez, M.A.

Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series
pp. 390-394(5)
Authors: Lonsdale-Eccles, A.A.; Velangi, S.

Treatment of acne with topical antibiotics: lessons from clinical studies
pp. 395-403(9)
Authors: Simonart, T.; Dramaix, M.

Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: a single-blinded, randomized controlled trial
pp. 404-412(9)
Authors: Li, G.L.; Van Steeg, T.J.; Putter, H.; Van Der Spek, J.; Pavel, S.; Danhof, M.; Bouwstra, J.A.

Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies
pp. 413-416(4)
Authors: Hinterhuber, G.; Binder, M.; Marquardt, Y.; Cauza, K.; Riedl, E.; Rappersberger, K.; Wolff, K.; Foedinger, D.

Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients
pp. 417-423(7)
Authors: Vila, A.T.; Puig, L.; Fernández-Figueras, M.T.; Laiz, A.M.; Vidal, D.; Alomar, A.

Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland
pp. 424-427(4)
Authors: Gudi, V.S.; White, M.I.; Cruickshank, N.; Herriot, R.; Edwards, S.L.; Nimmo, F.; Ormerod, A.D.

The first case of cutaneous mucormycosis caused by Rhizopus azygosporus
pp. 428-430(3)
Authors: Fujimoto, A.; Nagao, K.; Tanaka, K.; Yamagami, J.; Udagawa, S-I.; Sugiura, M.

Elastosis perforans serpiginosa-like pseudoxanthoma elasticum in a child with severe Moya Moya disease
pp. 431-434(4)
Authors: Meyer, S.; Zanardo, L.; Kaminski, W.E.; Horn, P.; Schmitz, G.; Hohenleutner, U.; Herrmann, W.A.; Landthaler, M.; Vogt, T.

Bullous delayed pressure urticaria: pathogenic role for eosinophilic granulocytes?
pp. 435-439(5)
Authors: Kerstan, A.; Rose, C.; Simon, D.; Simon, H-U.; Bröcker, E-B.; Trautmann, A.; Leverkus, M.

Cold urticaria; disease course and outcome – an investigation of 85 patients before and after therapy
pp. 440-441(2)

Docetaxel-induced recall dermatitis on previous laser treatment sites
pp. 441-443(3)

Cyclophosphamide–dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement
pp. 443-445(3)

Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin
pp. 445-446(2)

Inpatient compliance of topical applications
pp. 446-448(3)

Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor- inhibitor infliximab
pp. 448-449(2)

Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab
pp. 449-451(3)

Generalized cowpox infection probably transmitted from a rat
pp. 451-453(3)

More skin cancer detected from nonurgent referrals
pp. 453-454(2)

High local interleukin 5 production in granuloma faciale (eosinophilicum): role of clonally expanded skin-specific CD4+ cells
pp. 454-457(4)

Vulval adenosis associated with toxic epidermal necrolysis
pp. 457-458(2)

Who should treat patients with primary melanoma?: reply from authors
pp. 458-459(2)

Who should treat patients with primary melanoma?
pp. 459-460(2)

The place of botulinum toxin type A in the treatment of focal hyperhidrosis
pp. 460-461(2)

The place of botulinum toxin type A in the treatment of focal hyperhidrosis: reply from authors
pp. 461-461(1)

A new type of erythrokeratoderma, or KLICK syndrome?
pp. 461-461(1)

A new type of erythrokeratoderma, or KLICK syndrome?: reply from authors
pp. 462-462(1)

Evidence for a role of type I interferons in the pathogenesis of dermatomyositis
pp. 462-463(2)

Evidence for a role of type I interferons in the pathogenesis of dermatomyositis: reply from authors
pp. 463-464(2)

News and Notices
pp. 464-466(3)

BSPD Abstracts
pp. 467-473(7)

BEES Abstracts
pp. 474-476(3)